Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line
- PMID: 10355896
- DOI: 10.1006/niox.1999.0207
Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line
Abstract
A stably transfected soluble guanylate cyclase (sGC, alpha1 and beta1 subunits of the rat lung enzyme)-overexpressing CHO cell line was generated for the characterization of different types of activators of the soluble guanylate cyclase. Polyclonal antibodies directed against both subunits of the rat enzyme were used to detect both subunits in the cytosol of the transfected CHO cells. We studied the effects of different nitric oxide (NO) donors like SNP and DEA/NO and, in particular, the direct, NO-independent stimulator of the soluble guanylate cyclase 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1), on intracellular guanosine 3',5'-cyclic monophosphate (cGMP) production. DEA/NO (0.01-3 microM), SNP (1-10 microM), and YC-1 (1-10 microM) induced a concentration-dependent intracellular cGMP increase with maximal effects of 16-fold (3 microM DEA/NO), 8-fold (10 microM SNP), and 6-fold (10 microM YC-1) stimulation compared to controls, respectively. In addition, a synergistic effect of the combination of the NO donor and YC-1 could be observed with a maximal stimulation of 64-fold by SNP (10 microM) and YC-1 (10 microM). 1H-(1,2,4)-Oxadiazolo-(4,3-a)-6-bromo-quinoxazin-1-one (ODQ, 10 microM), a potent and selective inhibitor of sGC, inhibited both the single effects of NO donors [DEA/NO (3 microM), 77%; SNP (3 microM), 83%] and YC-1 [YC-1 (3 microM), 82%], but moreover the synergistic effects between NO donors and YC-1 [DEA/NO (3 microM) + YC-1 (3 microM), 81%; SNP (3 microM) + YC-1 (3 microM),89%] on intracellular cGMP production. In summary,we have generated a simple, sensitive, and useful bioassay method to characterize all types of sGC activators on the cellular level without the need of primary cell culture, several transfections, or purifying enzyme from biological materials.
Similar articles
-
Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.Br J Pharmacol. 1997 Feb;120(4):681-9. doi: 10.1038/sj.bjp.0700982. Br J Pharmacol. 1997. PMID: 9051308 Free PMC article.
-
Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.Can J Physiol Pharmacol. 2007 May;85(5):521-6. doi: 10.1139/y07-033. Can J Physiol Pharmacol. 2007. PMID: 17632587
-
Purified soluble guanylyl cyclase expressed in a baculovirus/Sf9 system: stimulation by YC-1, nitric oxide, and carbon monoxide.J Mol Med (Berl). 1999 Jan;77(1):14-23. doi: 10.1007/s001090050292. J Mol Med (Berl). 1999. PMID: 9930922
-
[Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].Biomed Khim. 2007 Jul-Aug;53(4):385-99. Biomed Khim. 2007. PMID: 18035720 Review. Russian.
-
Salutary properties of YC-1 in the cardiovascular and hematological systems.Curr Med Chem Cardiovasc Hematol Agents. 2004 Oct;2(4):343-59. doi: 10.2174/1568016043356200. Curr Med Chem Cardiovasc Hematol Agents. 2004. PMID: 15320784 Review.
Cited by
-
NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle.Br J Pharmacol. 2002 Jul;136(5):773-83. doi: 10.1038/sj.bjp.0704778. Br J Pharmacol. 2002. PMID: 12086987 Free PMC article.
-
NO-independent regulatory site of direct sGC stimulators like YC-1 and BAY 41-2272.BMC Pharmacol. 2001;1:13. doi: 10.1186/1471-2210-1-13. Epub 2001 Dec 28. BMC Pharmacol. 2001. PMID: 11801189 Free PMC article.
-
Pharmacological actions of a novel NO-independent guanylyl cyclase stimulator, BAY 41-8543: in vitro studies.Br J Pharmacol. 2002 Jan;135(2):333-43. doi: 10.1038/sj.bjp.0704484. Br J Pharmacol. 2002. PMID: 11815368 Free PMC article.
-
Distinct molecular requirements for activation or stabilization of soluble guanylyl cyclase upon haem oxidation-induced degradation.Br J Pharmacol. 2009 Jul;157(5):781-95. doi: 10.1111/j.1476-5381.2009.00263.x. Epub 2009 May 18. Br J Pharmacol. 2009. PMID: 19466990 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources